LOC388436 inhibitors constitute a specialized chemical class designed to selectively target and modulate the function of the non-coding RNA LOC388436. As a member of the extensive family of non-coding RNAs, LOC388436 is categorized as a long intergenic non-protein coding RNA (lincRNA). Despite its lack of protein-coding capacity, lincRNAs have emerged as crucial regulators of diverse cellular processes. The inhibitors developed for LOC388436 are intricately designed to interact with the specific molecular structure of this non-coding RNA, aiming to disrupt its normal interactions within the cellular environment and potentially influence various cellular regulatory pathways.
The molecular architecture of LOC388436 inhibitors is precisely tailored to engage specific binding sites on the RNA molecule, inducing changes in its conformation and dynamics. In laboratory research, these inhibitors serve as essential tools, enabling scientists to probe the nuanced functions of LOC388436 in various cellular contexts. By manipulating the function of LOC388436, researchers aim to unravel the complex mechanisms of non-coding RNA-mediated regulation, contributing to a deeper understanding of the intricate network of molecular players orchestrating cellular processes and potential roles in cellular homeostasis. The study of LOC388436 inhibitors stands at the forefront of advancing our comprehension of non-coding RNA biology and the nuanced roles these molecules play in the intricate web of cellular regulatory mechanisms.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $173.00 $418.00 | 43 | |
Intercalates DNA and can inhibit the transcription of genes, potentially affecting protein expression. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $40.00 $82.00 $256.00 | 127 | |
Inhibits eukaryotic protein synthesis by interfering with the translocation step in protein elongation. | ||||||
Chloramphenicol | 56-75-7 | sc-3594 | 25 g | $53.00 | 10 | |
Binds to bacterial ribosomes and inhibits protein synthesis, used in research to study protein expression. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
Binds to DNA and prevents RNA synthesis by inhibiting RNA polymerase, thereby reducing protein expression. | ||||||
Puromycin | 53-79-2 | sc-205821 sc-205821A | 10 mg 25 mg | $163.00 $316.00 | 436 | |
Causes premature chain termination during translation by acting as an analog of aminoacyl-tRNA. | ||||||
Emetine | 483-18-1 | sc-470668 sc-470668A sc-470668B sc-470668C | 1 mg 10 mg 50 mg 100 mg | $352.00 $566.00 $1331.00 $2453.00 | ||
Inhibits protein synthesis by blocking ribosomal translocation. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $97.00 $254.00 | 36 | |
Inhibits protein synthesis by interfering with peptidyl transferase activity of the ribosome. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $260.00 $1029.00 | 26 | |
Inhibits RNA polymerase II, which is responsible for mRNA synthesis, thus could decrease protein expression. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $57.00 $182.00 $92.00 | 21 | |
Inhibits DNA topoisomerase I, leading to reduced transcription and protein expression. | ||||||
Mycophenolic acid | 24280-93-1 | sc-200110 sc-200110A | 100 mg 500 mg | $68.00 $261.00 | 8 | |
Inhibits inosine-5'-monophosphate dehydrogenase, leading to decreased nucleotide synthesis and reduced RNA and protein synthesis. | ||||||